Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
Malak Elsobky, MD
Pfizer Canada, Canada
Disclosure(s): Pfizer: Stocks/Bonds (Public Company)
Poster(s):
(P-40) Impact of case and control selection on influenza vaccine effectiveness (VE) among adults aged 40 years and older hospitalized with acute respiratory illness (ARI) during 2022-2023 using a test negative design (TND): secondary analysis of the North America multi-specimen study
Thursday, October 17, 2024
12:15 PM – 1:30 PM
US PT
